CompoAtlas

Alvityl® Hydrink Vitalité

Food supplement declared in France, decision dated 23 July 2025

Alvityl® Hydrink Vitalité, from LABORATOIRES URGO HEALTHCARE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Pantothenic acid (vitamin B5), Biotin (vitamin B8), Calcium, Folate (vitamin B9), Magnesium. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
LABORATOIRES URGO HEALTHCARE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 à 2 comprimés par jour
Directions for use
1 comprimé effervescent à dissoudre dans un verre d’eau (100 ml), jusqu'à 2 fois par jour
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women, Kidney failure
Objectives stated by the manufacturer (these are not authorised claims)
Autre : fatigue, fortes chaleurs, Sport
Flavourings
pêche

Declaration 333351, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothenate, calciumPantothenic acid (vitamin B5)no limit (insufficient data)dose annulled by the French Council of State in 2011
D-biotinBiotin (vitamin B8)no limit (insufficient data)dose annulled by the French Council of State in 2011
calcium carbonateCalcium2,500 mg800 mg
pteroylmonoglutamic acidFolate (vitamin B9)1,000 µg200 µg
magnesium carbonateMagnesium250 mg300 mg
nicotinamideNicotinamide (vitamin B3)900 mg54 mg
potassium bicarbonatePotassiumno limit (insufficient data)80 mg
potassium chloridePotassiumno limit (insufficient data)80 mg
sodium bicarbonateSodiumno limit (insufficient data)no fixed dose
thiamin hydrochlorideVitamin B1 (thiamine)no limit (insufficient data)dose annulled by the French Council of State in 2011
cyanocobalaminVitamin B12no adverse effect defineddose annulled by the French Council of State in 2011
pyridoxine hydrochlorideVitamin B612 mg2 mg
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg

Additives

E955, E330

Other ingredients

dextrose-glucose, amidon de maïs

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l’adolescent à partir de 12 ans. Déconseillé aux personnes suivant un régime hyposodé ou souffrant d’insuffisance rénale. Ne pas consommer en cas de prise concomitante de médicament, quel qu’il soit. Déconseillé aux femmes enceintes ou allaitantes sans avis médical. Ne peut remplacer une alimentation variée et équilibrée ainsi qu’un mode de vie sain. Tenir hors de portée des jeunes enfants. Ne pas consommer en cas de prise concomitante de médicament, quel qu’il soit.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Alvityl® Hydrink Vitalité: composition and regulation”, https://compoatlas.com/en/supplements/products/333351-alvityl-hydrink-vitalite, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line